Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leyvraz

Showing results (291-300 of 405) with videos related to

Pageof 41
Sort By:
The Journal of Bone and Joint Surgery. British Volume|August 27, 1999
Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump systemJ Blanchard, J Y Meuwly, P F Leyvraz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncologie Thoracique des Régions AlpinesP Alberto, R O Mirimanoff, B Mermillod, et al.
Critical Reviews in Oncology/Hematology|February 22, 2002
High-dose chemotherapy for solid tumors: results of the EBMTGiovanni Rosti, Patrizia Ferrante, Jonathan Ledermann, et al.
Revue Medicale Suisse|July 12, 2008
[Systemic treatment of metastatic colorectal cancer]M Montemurro, L Achtari, A Röth, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2013
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumabChristiane Meyer, Laurène Cagnon, Carla M Costa-Nunes, et al.
Schweizerische Medizinische Wochenschrift|February 11, 1995
[Participation in multicenter studies as quality control in the therapy of Hodgkin disease: an interim report]A Lohri, S Leyvraz, T Cerny, et al.
Revue Medicale Suisse|October 24, 2019
[Preimplantation genetic testing: legal and ethical aspects in clinical practice]Jeanne-Pascale Simon, Pierre-Antoine Pradervand, Viviane Cina, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 20, 1998
Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapyR J Salmon, C Levy, C Plancher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, P Alberto, C Hürny, et al.
Lung Cancer (Amsterdam, Netherlands)|August 12, 2008
Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancerTim Eisen, Nick Thatcher, Serge Leyvraz, et al.
Pageof 41

Showing results (291-300 of 405) with videos related to

Sort By:
Pageof 41
The Journal of Bone and Joint Surgery. British Volume|August 27, 1999
Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump systemJ Blanchard, J Y Meuwly, P F Leyvraz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncologie Thoracique des Régions AlpinesP Alberto, R O Mirimanoff, B Mermillod, et al.
Critical Reviews in Oncology/Hematology|February 22, 2002
High-dose chemotherapy for solid tumors: results of the EBMTGiovanni Rosti, Patrizia Ferrante, Jonathan Ledermann, et al.
Revue Medicale Suisse|July 12, 2008
[Systemic treatment of metastatic colorectal cancer]M Montemurro, L Achtari, A Röth, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2013
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumabChristiane Meyer, Laurène Cagnon, Carla M Costa-Nunes, et al.
Schweizerische Medizinische Wochenschrift|February 11, 1995
[Participation in multicenter studies as quality control in the therapy of Hodgkin disease: an interim report]A Lohri, S Leyvraz, T Cerny, et al.
Revue Medicale Suisse|October 24, 2019
[Preimplantation genetic testing: legal and ethical aspects in clinical practice]Jeanne-Pascale Simon, Pierre-Antoine Pradervand, Viviane Cina, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 20, 1998
Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapyR J Salmon, C Levy, C Plancher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, P Alberto, C Hürny, et al.
Lung Cancer (Amsterdam, Netherlands)|August 12, 2008
Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancerTim Eisen, Nick Thatcher, Serge Leyvraz, et al.
Pageof 41